NCT04087876No Longer Available不适用
Expanded Access Use of Derazantinib for Patients With Locally Advanced, Inoperable or Metastatic iCCA Harbouring FGFR Genomic Alterations
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- No Longer Available
研究概览
简要总结
Basilea provided expanded access to derazantinib for patients with locally advanced, inoperable or metastatic intrahepatic cholangiocarcinoma (iCCA) with FGFR genomic alterations on a patient by patient basis while clinical development of derazantinib was ongoing.
研究设计
- 研究类型
- Expanded Access
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究者
相似试验
No Longer Available
不适用
An Expanded Access Study of Brigatinib for Patients With ALK-positive Advanced Non-Small Cell Lung CancerAdvanced MalignanciesCarcinomaLung CancerNon-small Cell Lung CancerNCT02784158Ariad Pharmaceuticals
Available
不适用
Expanded Access to Ulixertinib (BVD-523) in Patients With Advanced MAPK Pathway-Altered MalignanciesSmall Bowel CancerNon Small Cell Lung CancerHead and Neck CancerMAPK Gene MutationKRAS Activating MutationBRAF Gene MutationNRAS Gene MutationHRAS Gene MutationMEK MutationERK MutationColorectal CancerOvarian CancerHepatocellular CarcinomaPancreatic CancerGastric CancerMelanomaBladder CancerGlioblastomaEsophageal CancerThyroid CancerCholangiocarcinomaNCT04566393xCures
Available
不适用
Individual Patient Compassionate Use of FedratinibMyelofibrosisNCT03723148Celgene
No Longer Available
不适用
Expanded Access for the Prevention of Acute Attacks of 1) Hereditary Angioedema (HAE) in Children and 2) Non-histaminergic Angioedema With Normal C1-Inhibitor (C1-INH) in Teenagers and AdultsHereditary Angioedema (HAE)AngioedemaNCT04583007Shire
No Longer Available
不适用
Expanded Access to TAK-113 for Adults With Metastatic Colorectal Cancer (mCRC)Colorectal CancerNCT06195514Takeda